Gaumann, A. K., F. Kiefer, J. Alfer, S. A. Lang, E. K. Geissler and G. Breier: Receptor tyrosine kinase inhibitors: Are they real tumor killers?. In: Int J Cancer 138, 3, 540-554 (2016).
url: http://www.ncbi.nlm.nih.gov/pubmed/25716346
Wang, L., R. Benedito, M. G. Bixel, D. Zeuschner, M. Stehling, L. Savendahl, J. J. Haigh, H. Snippert, H. Clevers, G. Breier, F. Kiefer and R. H. Adams: Identification of a clonally expanding haematopoietic compartment in bone marrow1. In: EMBO J 32, 2, 219-230 (2012).
Planas-Paz, L., B. Strilic, A. Goedecke, G. Breier, R. Fässler and E. Lammert: Mechanoinduction of lymph vessel expansion. In: EMBO Journal 31, 4, 788-804 (2012).
Ahlbrecht, K., J. Schmitz, U. Seay, C. Schwarz, R. Mittnacht-Kraus, A. Gaumann, R. V. Haberberger, S. Herold, G. Breier, F. Grimminger, W. Seeger and R. Voswinckel: Spatiotemporal expression of flk-1 in pulmonary epithelial cells during lung development. (2008).
url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18323533
Hammes, H.-P., J. Lin, P. Wagner, Y. Feng, F. vom Hagen, T. Krzizok, O. Renner, G. Breier, M. Brownlee and U. Deutsch: Angiopoietin-2 causes Pericyte Dropout in the Normal Retina. In: Diabetes 53, 1104-1110 (2004).
Voswinckel, R., T. Ziegelhoeffer, M. Heil, S. Kostin, G. Breier, T. Mehling, R. Haberberger, M. Clauss, A. Gaumann, W. Schaper and W. Seeger: Bone marrow derived progenitor cells do not contribute to pulmonary angiogenesis and vascular remodeling in compensatory lung growth.. In: Circulation Research submitted (2003).
Voswinckel, R., T. Ziegelhoeffer, M. Heil, S. Kostin, G. Breier, T. Mehling, R. Haberberger, M. Clauss, A. Gaumann, W. Schaper and W. Seeger: Circulating vascular progenitor cells do not contribute to compensatory lung growth.. In: Circulation Research 93, 4, 372-379 (2003).
Elvert, G., A. Kappel, R. Heidenreich, U. Englmeier, S. Lanz, T. Acker, M. Rauter, K. Plate, M. Siewecke, G. Breier and I. Flamme: Cooperative interaction of hypoxia-inducible factor 2a and ETS-1 in the transcriptional activation of Flk-1. In: Journal of Biological Chemistry (2002).
doi: published online as 10.1074/jbc.M211298200 on December 2, 2002)
Leenders, W., N. Lubsen, M. v. Altena, M. Clauss, M. Deckers, C. Löwik, G. Breier, D. Ruiter and R. d. Waal: Design of a variant of vascular endothelial growth factor-A (VEGF-A) antagonizing KDR/Flk-1 and Flt-1.. In: Laboratory Investigation 82, 473-481 (2002).
Hirai, H., M. Ogawa, N. Suzuki, M. Yamamoto, G. Breier, O. Mazda, J. Imanishi and S. I. Nishikawa: Hemogenic and non-hemogenic endothelium can be distinguished by the activity of fetal liver kinase (Flk)-1 promoter/enhancer during mouse embryogenesis. In: Blood (2002).
doi: (prepublished online as DOI 10.1182/blood-2002-02-0655
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.